Aplastic anemia occurring as amegakaryocytic thrombocytopenia with and without an inhibitor of granulopoiesis.
Two patients with aplastic anemia evolving from cellular bone marrows with severely diminished megakaryocytes are reported. During this evolution a plasma inhibitor of in vitro granulocyte-macrophage colony formation was demonstrated associated with non-A, non-B hepatitis in one patient. The second patient had abnormal liver function that corrected after the delivery of a normal newborn but there was persistence of pancytopenia without evidence of a plasma inhibitor.
D000328:Adult; D000741:Anemia, Aplastic / Q000097:blood / Q000150:complications*; D001853:Bone Marrow / Q000473:pathology; D003114:Colony-Forming Units Assay; D005260:Female; D006098:Granulocytes; D006131:Growth Inhibitors / Q000097:blood; D006526:Hepatitis C / Q000150:complications; D006801:Humans; D007958:Leukocyte Count; D008264:Macrophages; D008297:Male; D008533:Megakaryocytes; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000209:etiology*; D013921:Thrombocytopenia / Q000209:etiology*
D006131:Growth Inhibitors